- Home
- ORMP vs HBIO Comparison
ORMP vs HBIO Comparison
Compare ORMP & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORMP
- HBIO
- Stock Information
- Founded
- ORMP 2002
- HBIO 1901
- Country
- ORMP United States
- HBIO United States
- Employees
- ORMP N/A
- HBIO N/A
- Industry
- ORMP Biotechnology: Pharmaceutical Preparations
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- ORMP Health Care
- HBIO Industrials
- Exchange
- ORMP Nasdaq
- HBIO Nasdaq
- Market Cap
- ORMP 94.2M
- HBIO 106.4M
- IPO Year
- ORMP N/A
- HBIO 2000
- Fundamental
- Price
- ORMP $2.31
- HBIO $2.16
- Analyst Decision
- ORMP Hold
- HBIO
- Analyst Count
- ORMP 1
- HBIO 0
- Target Price
- ORMP N/A
- HBIO N/A
- AVG Volume (30 Days)
- ORMP 108.3K
- HBIO 155.6K
- Earning Date
- ORMP 12-03-2024
- HBIO 11-07-2024
- Dividend Yield
- ORMP N/A
- HBIO N/A
- EPS Growth
- ORMP N/A
- HBIO N/A
- EPS
- ORMP 0.11
- HBIO N/A
- Revenue
- ORMP N/A
- HBIO $97,732,000.00
- Revenue This Year
- ORMP N/A
- HBIO N/A
- Revenue Next Year
- ORMP N/A
- HBIO N/A
- P/E Ratio
- ORMP $21.42
- HBIO N/A
- Revenue Growth
- ORMP N/A
- HBIO N/A
- 52 Week Low
- ORMP $2.00
- HBIO $1.99
- 52 Week High
- ORMP $3.67
- HBIO $5.56
- Technical
- Relative Strength Index (RSI)
- ORMP 48.78
- HBIO 43.02
- Support Level
- ORMP $2.13
- HBIO $1.99
- Resistance Level
- ORMP $2.31
- HBIO $2.61
- Average True Range (ATR)
- ORMP 0.10
- HBIO 0.16
- MACD
- ORMP -0.00
- HBIO -0.02
- Stochastic Oscillator
- ORMP 60.00
- HBIO 20.48
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.